Monika Haack

Monika Haack

Auto-generated profile, based on publicly available information

Monika Haack

Department of Neurology, Beth Israel Deaconess Medical Center, Boston, MA, USA

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 June 2019 in Neuropsychopharmacology
Verified
Journal Article
Closed access
PDF file
MHMonika Haack
Monika Haack
NSNorah Simpson
Norah Simpson
NSNavil Sethna
Navil Sethna
SKSatvinder Kaur
Satvinder Kaur
JMJanet Mullington
Janet Mullington

1 September 2007 in SLEEP
Verified
Journal Article
Open access
PDF file
MHMonika Haack
Monika Haack
ESElsa Sanchez
Elsa Sanchez
JMJanet M. Mullington
Janet M. Mullington
Sleep disturbances, pain, and inflammation co-occur in various medical conditions, but their interrelationships are poorly understood. We investigated the effects of reduced sleep duration (by approximately 50%) to 4 h/night across 10 days, on peripherally circulating inflammatory mediators. In addition, we tested the prediction that degree of inflammation is quantitatively related to the extent to which pain is increased in response to prolonged sleep restriction. Randomized, 16 day controlled in-laboratory study conducted in GCRC. Eighteen volunteers were randomly assigned to either 12 days of sleeping 8 h/night or 4 h/night. Participants rated mood and pain symptoms throughout experimental days. Urine was collected and blood was drawn frequently on the baseline day and after the 10th experimental day for 25 hours. Levels of plasma interleukin (IL)-6, serum C-reactive protein (CRP), plasma soluble tumor necrosis factor receptor p55 (sTNF-R p55), urinary levels of prostaglandin (PG) metabolites D2 and E2, subjective assessment of pain and tiredness-fatigue. IL-6 levels were elevated in the 4-h sleep condition over the 8-h sleep condition (P <0.05). CRP levels showed the same trend as IL-6, but did not differ significantly between groups (P = 0.11). Levels of sTNFR p55 were unchanged in both groups. PG E2 and 11β-F2α metabolite increased in 4-h sleepers, but did not differ significantly from the 8-h sleepers. Elevated IL-6 levels were strongly associated with increased pain ratings in response to sleep restriction (r = 0.67, P <0.01), and this association could not be explained by elevations in tiredness-fatigue. Insufficient sleep quantity may facilitate and/or exacerbate pain through elevations of IL-6. In disorders where sleep disturbances are common, insufficient sleep quantity itself may establish and maintain its co-occurrence with pain and increased inflammation.

16 January 2020 in JCI Insight
Verified
Journal Article
Open access
PDF file
JHJeffrey A. Haspel
Jeffrey A. Haspel
RARon Anafi
Ron Anafi
MBMarishka K. Brown
Marishka K. Brown
NCNicolas Cermakian
Nicolas Cermakian
CDChristopher Depner
Christopher Depner
LSLaura A. Solt
Laura A. Solt
Recent discoveries demonstrate a critical role for circadian rhythms and sleep in immune system homeostasis. Both innate and adaptive immune responses — ranging from leukocyte mobilization, trafficking, and chemotaxis to cytokine release and T cell differentiation —are mediated in a time of day–dependent manner. The National Institutes of Health (NIH) recently sponsored an interdisciplinary workshop, “Sleep Insufficiency, Circadian Misalignment, and the Immune Response,” to highlight new research linking sleep and circadian biology to immune function and to identify areas of high translational potential. This Review summarizes topics discussed and highlights immediate opportunities for delineating clinically relevant connections among biological rhythms, sleep, and immune regulation.

1 September 2009 in Pain
Verified
Journal Article
Closed access
MHMonika Haack
Monika Haack
ELErin Lee
Erin Lee
DCDaniel A. Cohen
Daniel A. Cohen
JMJanet M. Mullington
Janet M. Mullington
Insufficient duration of sleep is a highly prevalent behavioral pattern in society that has been shown to cause an increase in spontaneous pain and sensitivity to noxious stimuli. Prostaglandins (PGs), in particular PGE2, are key mediators of inflammation and pain, and we investigated whether PGE2 is a potential mediator in sleep-loss-induced changes in nociceptive processing. Twenty-four participants (7 females, age 35.1+/-7.1 years) stayed for 7 days in the Clinical Research Center. After two baseline days, participants were randomly assigned to either 3 days of 88 h of sleep deprivation (TSD, N=15) or 8h of sleep per night (N=9), followed by a night of recovery sleep. Participants rated the intensity of various pain-related symptoms every 2h across waking periods on computerized visual analog scales. PGE2 was measured in 24-h-urine collections during baseline and third sleep deprivation day. Spontaneous pain, including headache, muscle pain, stomach pain, generalized body pain, and physical discomfort significantly increased by 5-14 units on a 100-unit scale during TSD, compared to the sleep condition. Urinary PGE2 metabolite significantly increased by about 30% in TSD over sleep condition. TSD-induced increase in spontaneous pain, in particular headache and muscle pain, was significantly correlated with increase in PGE2 metabolite. Activation of the PGE2 system appears to be a potential mediator of increased spontaneous pain in response to insufficient sleep.

6 March 2012 in European journal of pain
Verified
Journal Article
Closed access
MHM. Haack
M. Haack
JSJ. Scott‐Sutherland
J. Scott‐Sutherland
GSG. Santangelo
G. Santangelo
NSN.S. Simpson
N.S. Simpson
NSN. Sethna
N. Sethna
JMJ.M. Mullington
J.M. Mullington

1 September 2017 in Pain
Verified
Journal Article
Closed access
NSNorah S. Simpson
Norah S. Simpson
JSJennifer Scott-Sutherland
Jennifer Scott-Sutherland
SGShiva Gautam
Shiva Gautam
NSNavil Sethna
Navil Sethna
MHMonika Haack
Monika Haack
Chronic pain conditions are highly comorbid with insufficient sleep. While the mechanistic relationships between the 2 are not understood, chronic insufficient sleep may be 1 pathway through which central pain-modulatory circuits deteriorate, thereby contributing to chronic pain vulnerability over time. To test this hypothesis, an in-laboratory model of 3 weeks of restricted sleep with limited recovery (5 nights of 4-hour sleep per night followed by 2 nights of 8-hour sleep per night) was compared with 3 weeks of 8-hour sleep per night (control protocol). Seventeen healthy adults participated, with 14 completing both 3-week protocols. Measures of spontaneous pain, heat-pain thresholds, cold-pain tolerance (measuring habituation to cold over several weeks), and temporal summation of pain (examining the slope of pain ratings during cold water immersion) were assessed at multiple points during each protocol. Compared with the control protocol, participants in the sleep-restriction protocol experienced mild increases in spontaneous pain (P < 0.05). Heat-pain thresholds decreased after the first week of sleep restriction (P < 0.05) but normalized with longer exposure to sleep restriction. By contrast, chronic exposure to restricted sleep was associated with decreased habituation to, and increased temporal summation in response to cold pain (both P < 0.05), although only in the past 2 weeks of the sleep-restriction protocol. These changes may reflect abnormalities in central pain-modulatory processes. Limited recovery sleep did not completely resolve these alterations in pain-modulatory processes, indicating that more extensive recovery sleep is required. Results suggest that exposure to chronic insufficient sleep may increase vulnerability to chronic pain by altering processes of pain habituation and sensitization.